Thymus: The next (re)generation

Immunological Reviews

Volumn 271, Issue 1, 2016, Pages 56-71

  Chaudhry, Mohammed S ^a   Velardi, Enrico ^a   Dudakov, Jarrod A ^a,b   van den Brink, Marcel R M ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Aging; Thymus damage; Tissue regeneration

Indexed keywords

ANDROGEN RECEPTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CASPASE 9; CHEMOKINE RECEPTOR CCR7; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ESTROGEN; FREE RADICAL; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; HOMING RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; L SELECTIN; OXYGEN RADICAL; PROGESTERONE; PROTEIN P53; SOMATOMEDIN; SOMATOMEDIN C; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TESTOSTERONE; VASCULOTROPIN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ACUTE GRAFT VERSUS HOST DISEASE; ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; AGING; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELLULAR IMMUNODEFICIENCY; CHEMOTHERAPY; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; GENETIC POLYMORPHISM; HEMATOPOIETIC STEM CELL; HORMONE ACTION; HUMAN; IMMUNE DYSREGULATION; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOSENESCENCE; INFECTION; IRRADIATION; LYMPHOID CELL; MEMORY T LYMPHOCYTE; NONHUMAN; OPPORTUNISTIC INFECTION; PERIPHERAL LYMPHOCYTE; PRE T LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; TESTICULAR FEMINIZATION; THYMOCYTE; THYMUS; THYMUS ATROPHY; THYMUS FUNCTION; TISSUE DEGENERATION; TISSUE ENGINEERING; TISSUE REGENERATION; UPREGULATION; VIRUS INFECTION; ANIMAL; BIOLOGICAL THERAPY; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; AGING; ANIMALS; BIOLOGICAL THERAPY; CLINICAL TRIALS AS TOPIC; DENDRITIC CELLS; FIBROBLAST GROWTH FACTOR 7; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-7; INTERLEUKINS; REGENERATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84963605327     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12418     Document Type: Article

References (214)

1. Hakim FT, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest 2005;115:930-939.
2. Bosch M, Khan FM, Storek J. Immune reconstitution after hematopoietic cell transplantation. Curr Opin Hematol 2012;19:324-335.
3. Wils E-J, et al. Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients. Haematologica 2011;96:1846-1854.
4. Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Oncologist 1999;4:370-378.
5. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-149.
6. Heng TSP, Goldberg GL, Gray DHD, Sutherland JS, Chidgey AP, Boyd RL. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol 2005;175:2982-2993.
7. Goldberg GL, et al. Sex steroid ablation enhances immune reconstitution following cytotoxic antineoplastic therapy in young mice. J Immunol 2010;184:6014-6024.
8. Fletcher AL, et al. Ablation and regeneration of tolerance-inducing medullary thymic epithelial cells after cyclosporine, cyclophosphamide, and dexamethasone treatment. J Immunol 2009;183:823-831.
9. Gray DHD, et al. Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood 2006;108:3777-3785.
10. Gray D, Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med 2007;204:2521-2528.
11. Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection of theT cell repertoire: what thymocytes see (and don't see). Nat Rev Immunol 2014;14:377-391.
12. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997;89:3700-3707.
13. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999;402:255-262.
14. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995;16:413-425.
15. Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R. The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Bone Marrow Transplant 1995;1:18-23.
16. Williams KM, Mella H, Lucas PJ, Williams JA, Telford W, Gress RE. Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury. Clin Transl Sci 2009;2:279-285.
17. Gentil Dit Maurin A, Lemercier C, Collin-Faure V, Marche PN, Jouvin-Marche E, Candéias SM. Developmental regulation of p53-dependent radiation-induced thymocyte apoptosis in mice. Clin Exp Immunol 2015;179:30-38.
18. Sano S, et al. Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity 2001;15:261-273.
19. Dudakov JA, et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 2012;336:91-95.
20. Zhang SL, et al. Chemokine treatment rescues profound T-lineage progenitor homing defect after bone marrow transplant conditioning in mice. Blood 2014;124:296-304.
21. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976;84:304-315.
22. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984;5:25-44.
23. Purton JF, et al. Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J Immunol 2004;173:3816-3824.
24. Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000;18:309-345.
25. Dooley J, Liston A. Molecular control over thymic involution: from cytokines and microRNA to aging and adipose tissue. Eur J Immunol 2012;42:1073-1079.
26. Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med 1994;179:1835-1846.
27. Mittelstadt PR, Monteiro JP, Ashwell JD. Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness. J Clin Invest 2012;122:2384-2394.
28. Vacchio MS, Lee JY, Ashwell JD. Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation. J Immunol 1999;163:1327-1333.
29. Steinmann GG, Klaus B, Müller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985;22:563-575.
30. Dixit VD, Sridaran R, Edmonsond MA, Taub D, Thompson WE. Gonadotropin-releasing hormone attenuates pregnancy-associated thymic involution and modulates the expression of antiproliferative gene product prohibitin. Endocrinology 2003;144:1496-1505.
31. + double-positive thymocytes via TNF-alpha. Eur J Immunol 2000;30:2586-2592.
32. Olsen NJ, Watson MB, Henderson GS, Kovacs WJ. Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice. Endocrinology 1991;129:2471-2476.
33. Lai KP, et al. Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy. Mol Endocrinol 2013;27:25-37.
34. Olsen NJ, Olson G, Viselli SM, Gu X, Kovacs WJ. Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology 2001;142:1278-1283.
35. Williams KM, et al. CCL25 increases thymopoiesis after androgen withdrawal. Blood 2008;112:3255-3263.
36. Velardi E, et al. Sex steroid blockade enhances thymopoiesis by modulating Notch signaling. J Exp Med 2014;211:2341-2349.
37. Dudakov JA, Goldberg GL, Reiseger JJ, Chidgey AP, Boyd RL. Withdrawal of sex steroids reverses age- and chemotherapy-related defects in bone marrow lymphopoiesis. J Immunol 2009;182:6247-6260.
38. Dudakov JA, Goldberg GL, Reiseger JJ, Vlahos K, Chidgey AP, Boyd RL. Sex steroid ablation enhances hematopoietic recovery following cytotoxic antineoplastic therapy in aged mice. J Immunol 2009;183:7084-7094.
39. Raviola E, Karnovsky MJ. Evidence for a blood-thymus barrier using electron-opaque tracers. J Exp Med 1972;136:466-498.
40. Savino W. The thymus is a common target organ in infectious diseases. PLoS Pathog 2006;2:e62.
41. Nunes-Alves C, Nobrega C, Behar SM, Correia-Neves M. Tolerance has its limits: how the thymus copes with infection. Trends Immunol 2013;34:502-510.
42. Baroni CD, De Franceschi GS, Uccini S, Adorini L, Cnen GD, Ruco L. Biological effects of Escherichia coli lipopolysaccharide (LPS) in vivo. I. Selection in the mouse thymus of killer and helper cells. Immunology 1976;31:217-224.
43. Tsuji T, Asano Y, Handa T, Honma Y, Ichinose Y, Yokochi T. Induction of apoptosis in lymphoid tissues of mice after intramuscular injection of enterotoxigenic Escherichia coli enterotoxin. Immunobiology 2000;201:377-390.
44. Hick RW, Gruver AL, Ventevogel MS, Haynes BF, Sempowski GD. Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J Immunol 2006;177:169-176.
45. Gruver AL, Sempowski GD. Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol 2008;84:915-923.
46. + thymocyte depletion. Microb Pathog 2005;39:189-196.
47. Pérez AR, et al. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun 2007;21:890-900.
48. Deobagkar-Lele M, Chacko SK, Victor ES, Kadthur JC, Nandi D. Interferon-γ- and glucocorticoid-mediated pathways synergize to enhance death of CD4(+) CD8(+) thymocytes during Salmonella enterica serovar Typhimurium infection. Immunology 2013;138:307-321.
49. Su L, et al. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 1995;2:25-36.
50. Fang RHT, Colantonio AD, Uittenbogaart CH. The role of the thymus in HIV infection: a 10 year perspective. AIDS 2008;22:171-184.
51. Stanley SK, et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993;178:1151-1163.
52. Schmitt N, et al. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection. AIDS 2006;20:533-542.
53. Rozmyslowicz T, Murphy SL, Conover DO, Gaulton GN. HIV-1 infection inhibits cytokine production in human thymic macrophages. Exp Hematol 2010;38:1157-1166.
54. Mocarski ES, Bonyhadi M, Salimi S, McCune JM, Kaneshima H. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci USA 1993;90:104-108.
55. Mendes-da-Cruz DA, Silva JS, Cotta-de-Almeida V, Savino W. Altered thymocyte migration during experimental acute Trypanosoma cruzi infection: combined role of fibronectin and the chemokines CXCL12 and CCL4. Eur J Immunol 2006;36:1486-1493.
56. Nobrega C, et al. Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J Immunol 2010;184:351-358.
57. Ferrara JLM, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009;373:1550-1561.
58. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012;12:443-458.
59. Krenger W, Rossi S, Hollander GA. Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids. Transplantation 2000;69:2190-2193.
60. Hauri-Hohl MM, et al. Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood 2007;109:4080-4088.
61. Krenger W, Holländer GA. The immunopathology of thymic GVHD. Semin Immunopathol 2008;30:439-456.
62. Na I-K, et al. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease. J Clin Invest 2010;120:343-356.
63. Seddik M, Seemayer TA, Lapp WS. T cell functional defect associated with thymic epithelial cell injury induced by a graft-versus-host reaction. Transplantation 1980;29:61-66.
64. Lapp WS, Ghayur T, Mendes M, Seddik M, Seemayer TA. The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol Rev 1985;88:107-133.
65. Przybylski GK, Kreuzer K-A, Siegert W, Schmidt CA. No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GvHD. J Appl Genet 2007;48:397-404.
66. + T cells. J Immunol 2013;191:488-499.
67. + T cells in acute GVHD. Blood 2015;125:2720-2723.
68. Alpdogan O, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 2006;107:2453-2460.
69. Erickson M, et al. Regulation of thymic epithelium by keratinocyte growth factor. Blood 2002;100:3269-3278.
70. Dooley J, Erickson M, Larochelle WJ, Gillard GO, Farr AG. FGFR2IIIb signaling regulates thymic epithelial differentiation. Dev Dyn 2007;236:3459-3471.
71. Pan B, et al. Acute ablation of DP thymocytes induces up-regulation of IL-22 and Foxn1 in TECs. Clin Immunol 2014;150:101-108.
72. Chen L, Xiao S, Manley NR. Foxn1 is required to maintain the postnatal thymic microenvironment in a dosage-sensitive manner. Blood 2009;113:567-574.
73. Rode I, Martins VC, Küblbeck G, Maltry N, Tessmer C, Rodewald H-R. Foxn1 protein expression in the developing, aging, and regenerating thymus. J Immunol 2015;195:5678-5687.
74. Bredenkamp N, Nowell CS, Blackburn CC. Regeneration of the aged thymus by a single transcription factor. Development 2014;141:1627-1637.
75. Zook EC, et al. Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells. Blood 2011;118:5723-5731.
76. Goldberg GL, et al. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J Immunol 2007;178:7473-7484.
77. Park H-J, et al. Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim Biophys Acta 2007;1773:1462-1472.
78. Cuddihy AR, et al. Rapid thymic reconstitution following bone marrow transplantation in neonatal mice is VEGF-dependent. Biol Blood Marrow Transplant 2012;18:683-689.
79. Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Publ Group 2015;21:1424-1435.
80. Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology 2007;120:435-446.
81. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol 2013;14:428-436.
82. Gavazzi G, Krause K-H. Ageing and infection. Lancet Infect Dis 2002;2:659-666.
83. Pawelec G, Derhovanessian E, Larbi A. Immunosenescence and cancer. Crit Rev Oncol Hematol 2010;75:165-172.
84. Montoya-Ortiz G. Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis 2013;2013:267078.
85. Lynch HE, Goldberg GL, Chidgey A, van den Brink MRM, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol 2009;30:366-373.
86. Surh CD, Sprent J. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med 2000;192:F9-F14.
87. Murray JM, et al. Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Immunol Cell Biol 2003;81:487-495.
88. Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol 2011;11:289-295.
89. Mo R, et al. T cell chemokine receptor expression in aging. J Immunol 2003;170:895-904.
90. Haynes L, Swain SL. Why aging T cells fail: implications for vaccination. Immunity 2006;24:663-666.
91. Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006;5:136-139.
92. Coder BD, Wang H, Ruan L, Su D-M. Thymic involution perturbs negative selection leading to autoreactive T cells that induce chronic inflammation. J Immunol 2015;194:5825-5837.
93. + cells to hemopoietic growth factors and remodeling of cytokine network. J Gerontol A Biol Sci Med Sci 2000;55:B61-B66; discussion B67-70.
94. Douek DC, Koup RA. Evidence for thymic function in the elderly. Vaccine 2000;18:1638-1641.
95. Steinmann GG, Müller-Hermelink HK. Immunohistological demonstration of terminal transferase (TdT) in the age-involuted human thymus. Immunobiology 1984;166:45-52.
96. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 2006;6:127-135.
97. Zhang SL, Bhandoola A. Trafficking to the thymus. Curr Top Microbiol Immunol 2014;373:87-111.
98. Beerman I, Maloney WJ, Weissmann IL, Rossi DJ. Stem cells and the aging hematopoietic system. Curr Opin Immunol 2010;22:500-506.
99. Geiger H, de Haan G, Florian MC. The ageing haematopoietic stem cell compartment. Nat Rev Immunol 2013;13:376-389.
100. Gui J, Zhu X, Dohkan J, Cheng L, Barnes PF, Su D-M. The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells. Int Immunol 2007;19:1201-1211.
101. Min H, Montecino-Rodriguez E, Dorshkind K. Reduction in the developmental potential of intrathymic T cell progenitors with age. J Immunol 2004;173:245-250.
102. Thoman ML. The pattern of T lymphocyte differentiation is altered during thymic involution. Mech Ageing Dev 1995;82:155-170.
103. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol 1997;158:3037-3045.
104. Aw D, Silva AB, Palmer DB. Is thymocyte development functional in the aged? Aging (Albany NY) 2009;1:146-153.
105. + cells. J Immunol 1990;145:3209-3215.
106. Zhu X, Gui J, Dohkan J, Cheng L, Barnes PF, Su D-M. Lymphohematopoietic progenitors do not have a synchronized defect with age-related thymic involution. Aging Cell 2007;6:663-672.
107. Aw D, Silva AB, Maddick M, von Zglinicki T, Palmer DB. Architectural changes in the thymus of aging mice. Aging Cell 2008;7:158-167.
108. Yang H, et al. Axin expression in thymic stromal cells contributes to an age-related increase in thymic adiposity and is associated with reduced thymopoiesis independently of ghrelin signaling. J Leukoc Biol 2009;85:928-938.
109. Dixit VD. Thymic fatness and approaches to enhance thymopoietic fitness in aging. Curr Opin Immunol 2010;22:521-528.
110. Ortman CL, Dittmar KA, Witte PL, Le PT. Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int Immunol 2002;14:813-822.
111. Aspinall R, Andrew D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 2000;18:1629-1637.
112. Palmer DB. The effect of age on thymic function. Front Immunol 2013;4:1-6.
113. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today 1996;17:267-272.
114. Gui J, Mustachio LM, Su D-M, Craig RW. Thymus size and age-related thymic involution: early programming, sexual dimorphism, progenitors and stroma. Aging Dis 2012;3:280-290.
115. Hsu H-C, et al. Age-related thymic involution in C57BL/6J x DBA/2J recombinant-inbred mice maps to mouse chromosomes 9 and 10. Genes Immun 2003;4:402-410
116. Griffith AV, Fallahi M, Venables T, Petrie HT. Persistent degenerative changes in thymic organ function revealed by an inducible model of organ regrowth. Aging Cell 2012;11:169-177.
117. Yang H, Youm Y-H, Dixit VD. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol 2009;183:3040-3052.
118. Vallejo AN, Michel JJ, Bale LK, Lemster BH, Borghesi L, Conover CA. Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A. Proc Natl Acad Sci USA 2009;106:11252-11257.
119. Griffith AV, et al. Metabolic damage and premature thymus aging caused by stromal catalase deficiency. Cell Rep 2015;12:1071-1079.
120. Martins VC, et al. Thymus-autonomous T cell development in the absence of progenitor import. J Exp Med 2012;209:1409-1417.
121. Boehm T, Swann JB. Thymus involution and regeneration: two sides of the same coin? Nat Rev Immunol 2013;13:831-838.
122. Finch PW, Rubin JS. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 2004;91:69-136.
123. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 2006;281:15694-15700.
124. Ornitz DM, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996;271:15292-15297.
125. Alvarez I, et al. Central T cell tolerance: identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome. J Autoimmu 2015;60:12-19.
126. Rossi S, et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 2002;100:682-691.
127. Min D, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002;99:4592-4600.
128. Rossi SW, et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood 2007;109:3803-3811.
129. + cell transplantation in rhesus macaques. Biol Blood Marrow Transplant 2012;18:55-65.
130. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011;11:330-342.
131. + T cells. J Leukoc Biol 2014;95:117-127.
132. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998;20:394-397.
133. Noguchi M, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993. J Immunol 2008;181:5817-5827.
134. Alpdogan O, van den Brink M. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 2005;26:56-64.
135. -/- mice without affecting peripheral T cell homeostasis. J Immunol 2009;183:7645-7655.
136. Alpdogan O, et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001;98:2256-2265.
137. Abdul-Hai A, et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol 1996;24:1416-1422.
138. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001;97:1491-1497.
139. + memory cell pool. J Clin Invest 2005;115:1177-1187.
140. + T-cell responses after immunization with recombinant lentivector. Blood 2009;113:6629-6637.
141. Perales MA, et al. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood 2012;120:4882-4891.
142. Dudakov JA, Hanash AM, van den Brink MRM. Interleukin-22: immunobiology and pathology. Annu Rev Immunol 2015;33:747-785.
143. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011;12:21-27.
144. + innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011;12:320-326.
145. Cella M, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009;457:722-725.
146. Takatori H, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009;206:35-41.
147. + immature human natural killer cells in secondary lymphoid tissue. Immunity 2010;32:803-814.
148. Sawa S, et al. Lineage relationship analysis of ROROE≥t+ innate lymphoid cells. Science 2010;330:665-669.
149. Lindemans CA, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 2015;528:118-132.
150. Weigent DA. Lymphocyte GH-axis hormones in immunity. Cell Immunol 2013;285:118-132.
151. de Mello-Coelho V, et al. Growth hormone and its receptor are expressed in human thymic cells. Endocrinology 1998;139:3837-3842.
152. Murphy WJ, Durum SK, Anver MR, Longo DL. Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol 1992;148:3799-3805.
153. Redelman D, Welniak LA, Taub D, Murphy WJ. Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network. Cell Immunol 2008;252:111-121.
154. Chen BJ, Cui X, Sempowski GD, Chao NJ. Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp Hematol 2003;31:953-958.
155. Knyszynski A, Adler-Kunin S, Globerson A. Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow. Brain Behav Immun 1992;6:327-340.
156. Aiuti A, et al. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. Eur J Immunol 1999;29:1823-1831.
157. Tsuji Y, Kinoshita Y, Hato F, Tominaga K, Yoshida K. The in vitro proliferation of thymus epithelial cells stimulated with growth hormone and insulin-like growth factor-I. Cell Mol Biol 1994;40:1135-1142.
158. Alpdogan O, et al. Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation. Transplantation 2003;75:1977-1983.
159. Clark R. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr Rev 1997;18:157-179.
160. Montecino-Rodriguez E, Clark R, Dorshkind K. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology 1998;139:4120-4126.
161. Chu YW, et al. Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion. Blood 2008;112:2836-2846.
162. Napolitano LA, et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest 2008;118:1085-1098.
163. Hince M, Sakkal S, Vlahos K, Dudakov J, Boyd R, Chidgey A. The role of sex steroids and gonadectomy in the control of thymic involution. Cell Immunol 2008;252:122-138.
164. Sutherland JS, et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 2005;175:2741-2753.
165. Sutherland JS, et al. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res 2008;14:1138-1149.
166. Goldberg GL, et al. Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation. J Immunol 2009;182:5846-5854.
167. Henderson J. On the relationship of the thymus to the sexual organs: I. The influence of castration on the thymus. J Physiol 1904;31:222-229.
168. Goodall A. The post-natal changes in the thymus of guinea-pigs, and the effect of castration on thymus structure. J Physiol 1905;32:191-198.
169. Khong DM, et al. Enhanced hematopoietic stem cell function mediates immune regeneration following sex steroid blockade. Stem Cell Rep 2015;4:445-458.
170. Schmitt TM, Zúñiga-Pflücker JC. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002;17:749-756.
171. La Motte-Mohs RN, Herer E, Zuniga-Pflucker JC. Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 2005;105:1431-1439.
172. Dallas MH, Varnum-Finney B, Delaney C, Kato K, Bernstein ID. Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells. J Exp Med 2005;201:1361-1366.
173. Mohtashami M, Shah DK, Nakase H, Kianizad K, Petrie HT, Zuniga-Pflucker JC. Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes. J Immunol 2010;185:867-876.
174. Zakrzewski JL, et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med 2006;12:1039-1047.
175. Awong G, et al. Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood 2013;122:4210-4219.
176. Zakrzewski JL, et al. Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat Biotechnol 2008;26:453-461.
177. Markert ML, et al. Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med 1999;341:1180-1189.
178. Markert ML, et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood 2004;104:2574-2581.
179. Markert ML, et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 2007;109:4539-4547.
180. Marshall D, et al. T cell generation including positive and negative selection ex vivo in a three-dimensional matrix. J Hematother Stem Cell Res 2003;12:565-574.
181. Pinto S, Schmidt K, Egle S, Stark HJ, Boukamp P, Kyewski B. An organotypic coculture model supporting proliferation and differentiation of medullary thymic epithelial cells and promiscuous gene expression. J Immunol 2013;190:1085-1093.
182. Gill J, Malin M, Hollander GA, Boyd R. Generation of a complete thymic microenvironment by MTS24(+) thymic epithelial cells. Nat Immunol 2002;3:635-642.
183. Bennett AR, Farley A, Blair NF, Gordon J, Sharp L, Blackburn CC. Identification and characterization of thymic epithelial progenitor cells. Immunity 2002;16:803-814.
184. Bleul CC, Corbeaux T, Reuter A, Fisch P, Mönting JS, Boehm T. Formation of a functional thymus initiated by a postnatal epithelial progenitor cell. Nature 2006;441:992-996.
185. Ucar A, et al. Adult thymus contains FoxN1(-) epithelial stem cells that are bipotent for medullary and cortical thymic epithelial lineages. Immunity 2014;41:257-269.
186. Wong K, et al. Multilineage potential and self-renewal define an epithelial progenitor cell population in the adult thymus. Cell Rep 2014;8:1198-1209.
187. Parent AV, et al. Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell Stem Cell 2013;13:219-229.
188. Sun X, et al. Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo. Cell Stem Cell 2013;13:230-236.
189. + thymic epithelial progenitors. Stem Cell Rep 2014;2:925-937.
190. Su M, et al. Efficient in vitro generation of functional thymic epithelial progenitors from human embryonic stem cells. Sci Rep 2015;5:9882.
191. Bredenkamp N, Ulyanchenko S, O'Neill KE, Manley NR, Vaidya HJ, Blackburn CC. An organized and functional thymus generated from FOXN1-reprogrammed fibroblasts. Nat Cell Biol 2014;16:902-908.
192. Fan Y, et al. Bioengineering thymus organoids to restore thymic function and induce donor-specific immune tolerance to allografts. Mol Ther 2015;23:1262-1277.
193. Alpdogan O, et al. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 2003;112:1095-1107.
194. Andrew D, Aspinall R. Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol 2001;166:1524-1530.
195. Fry TJ, et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003;101:2294-2299.
196. Jacobs SR, Michalek RD, Rathmell JC. IL-7 is essential for homeostatic control of T cell metabolism in vivo. J Immunol 2010;184:3461-3469.
197. Phillips JA, Brondstetter TI, English CA, Lee HE, Virts EL, Thoman ML. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J Immunol 2004;173:4867-4874.
198. Li L, et al. IL-12 inhibits thymic involution by enhancing IL-7- and IL-2-induced thymocyte proliferation. J Immunol 2004;172:2909-2916.
199. Chen T, Burke KA, Zhan Y, Wang X, Shibata D, Zhao Y. IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation. Exp Hematol 2007;35:203-213.
200. Rafei M, Dumont-Lagace M, Rouette A, Perreault C. Interleukin-21 accelerates thymic recovery from glucocorticoid-induced atrophy. PLoS ONE 2013;8:e72801.
201. Ceredig R, Rauch M, Balciunaite G, Rolink AG. Increasing Flt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment. Blood 2006;108:1216-1222.
202. Fry TJ, et al. Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood 2004;104:2794-2800.
203. Kenins L, Gill JW, Boyd RL, Hollander GA, Wodnar-Filipowicz A. Intrathymic expression of Flt3 ligand enhances thymic recovery after irradiation. J Exp Med 2008;205:523-531.
204. Kenins L, Gill JW, Hollander GA, Wodnar-Filipowicz A. Flt3 ligand-receptor interaction is important for maintenance of early thymic progenitor numbers in steady-state thymopoiesis. Eur J Immunol 2010;40:81-90.
205. Wils EJ, et al. Flt3 ligand expands lymphoid progenitors prior to recovery of thymopoiesis and accelerates T cell reconstitution after bone marrow transplantation. J Immunol 2007;178:3551-3557.
206. Chu CH, et al. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol 2008;197:381-390.
207. + cells in poor mobilizers. Blood 2004;103:3287-3295.
208. Dixit VD, et al. Ghrelin promotes thymopoiesis during aging. J Clin Invest 2007;117:2778-2790.
209. Fewkes NM, Krauss AC, Guimond M, Meadors JL, Dobre S, Mackall CL. Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. Blood 2010;115:4120-4129.
210. Holland AM, Zakrzewski JL, Goldberg GL, Ghosh A, van den Brink MR. Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation in mouse and man. Semin Immunopathol 2008;30:479-487.
211. Arber C, et al. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood 2003;102:421-428.
212. Lai L, et al. Mouse embryonic stem cell-derived thymic epithelial cell progenitors enhance T-cell reconstitution after allogeneic bone marrow transplantation. Blood 2011;118:3410-3418.
213. Lai L, Jin J. Generation of thymic epithelial cell progenitors by mouse embryonic stem cells. Stem Cells 2009;27:3012-3020.
214. Chung B, et al. Engineering the human thymic microenvironment to support thymopoiesis in vivo. Stem Cells 2014;32:2386-2396.